| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
| Targets |
Endogenous metabolite; trehalase (EC 3.2.1.28); glucose transporters (GLUT2, SGLT1); autophagy pathway (mTOR-independent). Trehalose is hydrolyzed by trehalase to glucose, which is then absorbed via glucose transporters. It also acts as an mTOR-independent autophagy inducer and serves as a protein stabilizer and osmoprotectant.
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
As a labeled metabolite, D-(+)-Trehalose-d14 exhibits the same intrinsic biological activity as unlabeled trehalose. It is hydrolyzed by trehalase with Km values in the millimolar range. In vitro, trehalose protects cells against oxidative stress, dehydration, and protein aggregation. It also induces autophagy in cultured cells and stabilizes protein structure. |
| ln Vivo |
In vivo, D-(+)-Trehalose-d14 is used for metabolic tracing of trehalose absorption and metabolism. Following oral administration, trehalose is hydrolyzed to glucose in the small intestine. The d14 label enables quantification of trehalose-derived glucose in blood and tissues. Trehalose supplementation has shown neuroprotective and cardioprotective effects in animal models.
|
| Enzyme Assay |
For trehalase activity assays, trehalase is incubated with D-(+)-Trehalose-d14 (0.1-10 mM) in assay buffer at 37°C. Glucose release is measured by glucose oxidase/peroxidase assay or HPLC. For autophagy assays, cells are treated with trehalose, and LC3-II levels are assessed by Western blot. Products are analyzed by LC-MS/MS to quantify d14 enrichment.
|
| Cell Assay |
For cell culture studies, cells (neurons, cardiomyocytes, hepatocytes) are cultured in medium containing D-(+)-Trehalose-d14 (10-100 mM) for 24-72 hours. Cell viability is measured by MTT assay. Autophagy markers (LC3-II, p62) are assessed by Western blot. Protein aggregation is quantified by filter trap assay or immunofluorescence.
|
| Animal Protocol |
For in vivo metabolic tracing, mice receive D-(+)-Trehalose-d14 (100-500 mg/kg) via oral gavage or intraperitoneal injection. Blood and tissues (brain, heart, liver) are collected at defined time points (0-24 hours). Glucose-d14 enrichment in plasma and tissues is quantified by LC-MS/MS. For neuroprotection studies, mice receive trehalose daily for 1-4 weeks.
|
| References |
| Molecular Formula |
C12H8D14O11
|
|---|---|
| Molecular Weight |
356.38
|
| CAS # |
2028292-31-9
|
| Related CAS # |
D-(+)-Trehalose;99-20-7
|
| Appearance |
White to off-white solid powder
|
| SMILES |
O[C@@]([C@@]([C@]([C@](C([2H])([2H])O)([2H])O1)([2H])O)([2H])O)([2H])[C@@]1([2H])O[C@]2([2H])[C@]([C@@]([C@]([C@](C([2H])([2H])O)([2H])O2)([2H])O)([2H])O)([2H])O
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O: ~50 mg/mL (~140.3 mM; with ultrasonication)
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.8060 mL | 14.0300 mL | 28.0599 mL | |
| 5 mM | 0.5612 mL | 2.8060 mL | 5.6120 mL | |
| 10 mM | 0.2806 mL | 1.4030 mL | 2.8060 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.